Evaluation of the anti-tumor and anti-angiogenic effect of paclitaxel and thalidomide on the xenotransplanted oral squamous cell carcinoma

Cancer Letters

Volumn 163, Issue 2, 2001, Pages 191-200

  Myoung, Hoon ^a   Hong, Seong Doo ^a   Kim, Young Youn ^a   Hong, Sam Pyo ^a   Kim, Myung Jin ^a  

^a Seoul National University   (South Korea)

Author keywords

Anti angiogenesis; CD31; Oral squamous cell carcinoma; Paclitaxel; Thalidomide; Vascular endothelial growth factor

Indexed keywords

ANGIOGENESIS INHIBITOR; CD31 ANTIGEN; MESSENGER RNA; PACLITAXEL; THALIDOMIDE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CAPILLARY DENSITY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; MOUSE; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME; XENOGRAFT;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, SQUAMOUS CELL; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG THERAPY, COMBINATION; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; MICE; MICE, INBRED BALB C; MICE, NUDE; MOUTH NEOPLASMS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PACLITAXEL; RNA, MESSENGER; THALIDOMIDE; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA; MUS MUSCULUS;

EID: 0035952360     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00701-1     Document Type: Article

References (51)

1. Angiogenesis
2. What is the evidence that tumors are angiogenesis dependent?
3. Clinical research on antiangiogenic therapy
4. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
5. Relation of neovascularisation to metastasis of non-small-cell lung cancer
6. Tumor angiogenesis in advanced stage ovarian carcinoma
7. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas
8. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
9. Designing therapies that target tumor blood vessels
10. Vitaxin, a humanized monoclonal antibody to the vitronectin receptor (alphavbeta3), reduces neointimal hyperplasia and total vessel area after balloon injury in hypercholesterolemic rabbits
11. Intra-tumor injection of an angiogenesis inhibitor, TNP-470, in rabbits bearing VX2 carcinoma of the tongue
12. Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: Effects on tumor neovascularization
13. Thalidomide is an inhibitor of angiogenesis
14. Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization
15. Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor
16. Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits
17. Randomized phase II study of thalidomide in androgen independent prostate cancer (AIPC)
18. A phase II trial of the anti-angiogenic agent, thalidomide, in patients with recurrent high-grade gliomas
19. Thalidomide and chemotherapy combinations: Preliminary results of preclinical and clinical studies
20. Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms
21. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer
22. Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly(D,L-lactic acid)
23. Taxol encapsulation in poly(epsilon-caprolactone) microspheres
24. The microtubule-affecting drug paclitaxel has antiangiogenic activity
25. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol
26. Dual role of tumor necrosis factor-alpha in angiogenesis
27. Molecular mechanisms of blood vessel formation
28. Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma
29. Endothelial receptor tyrosine kinases involved in angiogenesis
30. Mechanisms of angiogenesis
31. Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia
32. Regulation of animal care and research? NIH's opinion
33. Leukocyte-induced angiogenesis and subcutaneous growth of B16 melanoma
34. JC70, a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections
35. Angiogenesis in ductal breast carcinoma. Comparison of microvessel density between primary tumor and lymph node metastasis
36. Angiogenesis in vulvar intraepithelial neoplasia
37. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
38. Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer
39. Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice
40. Effects of an anti-angiogenic agent, TNP-470, on the growth of oral squamous cell carcinomas
41. Angiogenic inhibition for the treatment of head and neck cancer
42. Failure of thalidomide to inhibit tumor growth and angiogenesis in vivo
43. Effect of thalidomide on tumor necrosis factor production and anti-tumor activity induced by 5,6-dimethylxanthenone-4-acetic acid
44. Thalidomide promotes metastasis of prostate adenocarcinoma cells (PA-III) in L-W rats
45. The effect of thalidomide on experimental tumors and metastases
46. Continuous low dose thalidomide: A phase II study in advanced melanoma, renal cell, ovarian, and breast cancer
47. Angiogenesis in the pathobiology and treatment of vascular and malignant diseases
48. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function
49. Tumor angiogenesis in T1 oral cavity squamous cell carcinoma: Role in predicting tumor aggressiveness
50. Experimental chemotherapy of xenotransplanted oral squamous epithelial carcinoma: Effectiveness of docetaxel (taxotere) in the nude mouse model
51. Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase